Uncategorized

Enterprise Development Programme – A meeting in the Ministry of Economy

A meeting with representatives of the Polish pharmaceutical industry, during which the Enterprise Development Programme project was presented, took place on 13 March 2013 in the Ministry of Economy. The programme regulates i.a. the mode of EU fund allocation for the years 2014-2020, and one of its primary objectives is boosting the innovativeness and competitivenessRead more »

Results of Celon’s anti-Alzheimer’s drug research on AD/PD 2013

Celon Pharma S.A. will present the results of one of its R&D projects focused on development of novel drugs for Alzheimer’s disease on The 11th International Conference on Alzheimer’s & Parkinson’s Diseases, Florence, Italy. Poster entitled: “Discovery of Novel GSK3beta Inhibitor Lead Structure Using Sequential Virtual Screening” will be displayed on 8 March 2013 inRead more »

BioTech-IP scientific-business brunch

Celon Pharma S.A. delegates will take part in the scientific-business brunch organized on 25 January 2013 in the International Institute of Molecular and Cell Biology in Warsaw. The aim of the meeting is to establish novel contacts and to tighten existing collaborations between companies with strong R&D background, academic institutions and investors of Mazovian Voivodeship.Read more »

Our results will be presented at EORTC!

We are happy to present the latest results from our R&D laboratoriries at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics held on 06-09 November in Dublin.  Our communication is entitled: “Discovery of CPL-407-22 – novel, potent and highly selective JAK2 kinase inhibitor.”

We are at the EACR in Barcelona

You can meet us at the The European Association for Cancer Research conference in Barcelona (7-10 July), where we present the results of our studies: NPM-ALK I1171T mutation confers resistance to crizotinib in anaplastic large cell lymphoma. Differential gene transcription response to the treatment with JAK2 inhibitors – Ruxolitinib, SAR302503 and LY2784544. Gene silencing ofRead more »

Meeting with representatives of the Chinese pharmaceutical and medical industry

A meeting between representatives of the Polish pharmaceutical industry and representatives of the Chinese pharmaceutical and medical industry took place on 4 July in the Polish Chamber of Commerce. The objective of the Chinese delegation’s visit was establishing business contacts. Celon Pharma Sp. z.o.o. was represented by Monika Lamparska-Przybysz (Head of the Innovative Medicines ResearchRead more »

Visit our booth on Bio-Forum 2012!

You are welcome to visit our booth on Bio-Forum – the biggest international event for bio-tech society in Central Europe (Brno, 23-24.05.2012)! We will be happy to meet you and to share with you information on Celon Pharma activities.

Dr. Jacek Jaworski’s lecture in Celon Pharma

Dr.  Jacek Jaworski (Head of  Laboratory of Molecular and Cellular Neurobiology, International Institute of Molecular and Cell Biology in Warsaw) presented  in Celon Pharma the lecture entitled   „mTOR kinase in physiology and neuropathology”.